Article EPAD LCS v500.0

Please note that a more recent version of these data can be found in the EPAD LCS v.IMI dataset.

European Prevention of Alzheimer's Disease (EPAD) Longitudinal Cohort Study (LCS) V500.0 data release.

To learn more about this dataset, visit the Data Information Pack here.

Manuscripts citing this dataset

  • Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study. 2020. DOI: 1186/s13195-020-00711-5
  • Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. 2020. DOI:
  • The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0. 2020. DOI: 14283/jpad.2019.46
  • Cognitive Dispersion Is Not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort. 2020. DOI: 3233/JAD-200514

Request Access

Data access can be requested via AD Workbench FAIR portal here. Access requests are reviewed by the EPAD team and the dataset will be automatically delivered to your workspace Inbox upon approval. Biological samples are also requestable via ADDI.

Data Use Agreement

The dataset terms of usage can be accessed here.

Publishing results using this dataset?

The dataset owner has specified that when publishing results using this dataset, EPAD and their funders are acknowledged. The specifications on how to provide the correct acknowledgement can be found here.

For a more in detail outline on EPAD’s policies for publication and publication credits, see EPAD Policy for publication here.


Post a question or thought about this dataset here.